Work

A first-in-human study of stx-0712, a CCR2+ cytotoxicity targeting chimera (CyTAC™) in patients with chronic myelomonocytic leukemia (CMML) and Acute Myeloid Leukemia (AML)

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-3874

Authors: Guillermo Montalban-Bravo, Courtney DiNardo, Peter Greenberg, Richard Stone, Eric Padron, David Sallman, Curtis Lachowiez, Jonathan Abbas, Abhishek Mangaonkar, Mrinal Patnaik, Marissa Timothy, Alonzo Martinez, Ewelina Morawa, Brandon Turunen, Philip Vickers, Sergio Santillana

Institutions: The University of Texas MD Anderson Cancer Center, Stanford Medicine, Stanford University, Dana-Farber Cancer Institute, Moffitt Cancer Center, Oregon Health & Science University, Tennessee Oncology, Mayo Clinic

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417007346

Cites:

Cited by:

Related to: